Document is current
Any future updates will be listed below
-
Authors
Vakulskas, Christopher A. https://orcid.org/0000-0001-8510-4332
Dever, Daniel P.
Rettig, Garrett R. https://orcid.org/0000-0003-4634-5787
Turk, Rolf https://orcid.org/0000-0003-1283-9594
Jacobi, Ashley M. https://orcid.org/0000-0002-9364-6518
Collingwood, Michael A. https://orcid.org/0000-0002-8849-4038
Bode, Nicole M. https://orcid.org/0000-0001-7209-303X
McNeill, Matthew S.
Yan, Shuqi
Camarena, Joab
Lee, Ciaran M. https://orcid.org/0000-0002-0789-9149
Park, So Hyun
Wiebking, Volker https://orcid.org/0000-0002-9429-5254
Bak, Rasmus O. https://orcid.org/0000-0002-7383-0297
Gomez-Ospina, Natalia https://orcid.org/0000-0002-6740-1154
Pavel-Dinu, Mara
Sun, Wenchao https://orcid.org/0000-0003-4306-2896
Bao, Gang
Porteus, Matthew H.
Behlke, Mark A. https://orcid.org/0000-0002-4218-857X
- License Information
-
More Information
Article History
Received: 19 December 2017
Accepted: 25 June 2018
First Online: 6 August 2018
Competing interests
: M.H.P. is a consultant and has equity interest in CRISPR Tx, but CRISPR Tx had no input or opinions on the subject matter described in this manuscript. C.A.V., G.R.R., R.T., A.M.J., M.A.C., N.M.B., M.S.M., S.Y., and M.A.B. are employees of Integrated DNA Technologies (IDT), which sells reagents similar to some described in the manuscript.
